Literature DB >> 11024472

Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods.

I Cielens1, V Ose, I Petrovskis, A Strelnikova, R Renhofa, T Kozlovska, P Pumpens.   

Abstract

Icosahedral virus-like particles (VLPs) of RNA phage Qbeta are stabilized by four disulfide bonds of cysteine residues 74 and 80 within the loop between beta-strands F and G (FG loop) of the monomeric subunits, which determine the five-fold and quasi-six-fold symmetry contacts of the VLPs. In order to reduce the stability of Qbeta VLPs, we mutationally converted the amino acid stretch 76-ANGSCD-81 within the FG loop into the 76-VGGVEL-81 sequence. It led to production in Escherichia coli cells of aberrant rod-like Qbeta VLPs, along with normal icosahedral capsids. The length of the rod-like particles exceeded 4-30 times the diameter of icosahedral Qbeta VLPs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024472     DOI: 10.1016/s0014-5793(00)02061-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Crystal packing of a bacteriophage MS2 coat protein mutant corresponds to octahedral particles.

Authors:  Pavel Plevka; Kaspars Tars; Lars Liljas
Journal:  Protein Sci       Date:  2008-07-28       Impact factor: 6.725

2.  Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation.

Authors:  Franziska Zabel; Antonia Fettelschoss; Monique Vogel; Pål Johansen; Thomas M Kündig; Martin F Bachmann
Journal:  Immunology       Date:  2017-01-05       Impact factor: 7.397

3.  Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.

Authors:  Baidong Hou; Philippe Saudan; Gary Ott; Matthew L Wheeler; Ming Ji; Lili Kuzmich; Linda M Lee; Robert L Coffman; Martin F Bachmann; Anthony L DeFranco
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

4.  Versatile virus-like particle carrier for epitope based vaccines.

Authors:  Alain C Tissot; Regina Renhofa; Nicole Schmitz; Indulis Cielens; Edwin Meijerink; Velta Ose; Gary T Jennings; Philippe Saudan; Paul Pumpens; Martin F Bachmann
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

5.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

6.  Engineered mutations change the structure and stability of a virus-like particle.

Authors:  Jason D Fiedler; Cody Higginson; Marisa L Hovlid; Alexander A Kislukhin; Alexandra Castillejos; Florian Manzenrieder; Melody G Campbell; Neil R Voss; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-25       Impact factor: 6.988

7.  Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1.

Authors:  Dominique Gatto; Thomas Pfister; Andrea Jegerlehner; Stephen W Martin; Manfred Kopf; Martin F Bachmann
Journal:  J Exp Med       Date:  2005-03-14       Impact factor: 14.307

8.  Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.

Authors:  Marika Doucet; Aadil El-Turabi; Franziska Zabel; Benjamin H M Hunn; Nora Bengoa-Vergniory; Milena Cioroch; Mauricio Ramm; Amy M Smith; Ariane Cruz Gomes; Gustavo Cabral de Miranda; Richard Wade-Martins; Martin F Bachmann
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

9.  Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.

Authors:  Eduardo Alves; Ahmed M Salman; Fabiana Leoratti; Cesar Lopez-Camacho; Martha Eva Viveros-Sandoval; Amar Lall; Aadil El-Turabi; Martin F Bachmann; Adrian V S Hill; Chris J Janse; Shahid M Khan; Arturo Reyes-Sandoval
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

10.  Vaccination against GIP for the treatment of obesity.

Authors:  Alma Fulurija; Thomas A Lutz; Katja Sladko; Melania Osto; Peter Y Wielinga; Martin F Bachmann; Philippe Saudan
Journal:  PLoS One       Date:  2008-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.